Prospective Randomized Phase III Trial of Etoposide/Cisplatin Versus High-Dose Epirubicin/Cisplatin in Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Prospective Randomized Phase III Trial of Etoposide/Cisplatin Versus High-Dose Epirubicin/Cisplatin in Small-Cell Lung Cancer

Published:2004-11 Issue:3 Volume:6 Page:175-183
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Artal-Cortés Angel,Gomez-Codina Jose,Gonzalez-Larriba Jose Luis,Barneto Isidoro,Carrato Alfredo,Isla Dolores,Camps Carlos,Garcia-Giron Carlos,Font Albert,Meana Alfredo,Lomas Maria,Vadell Catalina,Arrivi Antonio,Alonso Carmen,Maestu Inmaculada,Cambell Joaquin,Rosell Rafael

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Small-cell lung cancer;Simon;Chest,2003

2. Cancer statistics;Jamal;CA Cancer J Clin,2002

3. Management of small-cell cancer of the lung;Hansen;Lancet,1992

4. Twenty years of phase III trials for patients with extensive- stage small-cell lung cancer: perceptible progress;Chute;J Clin Oncol,1999

5. A meta-analysis of thoracic radiation therapy for small-cell lung cancer;Pignon;N Engl J Med,1992

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic evaluation of the efficacy‐effectiveness gap of systemic treatments in extensive disease small cell lung cancer;Pharmacoepidemiology and Drug Safety;2020-12-18

2. Systemic therapy for limited stage small cell lung carcinoma;Journal of Thoracic Disease;2020-10

3. A systematic review of survival following anti-cancer treatment for small cell lung cancer;Lung Cancer;2020-03

4. SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019);Clinical and Translational Oncology;2020-02

5. Real-world effectiveness and tolerability of small-cell lung cancer (SCLC) treatments: A systematic literature review (SLR);PLOS ONE;2019-07-18